Detalles de la búsqueda
1.
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Diabetologia
; 61(9): 1923-1934, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29971527
2.
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.
Diabetes Obes Metab
; 19(9): 1276-1288, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28345814
3.
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.
Diabetes Obes Metab
; 19(1): 49-60, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550386
4.
Predictive biomarkers of rapidly developing insulin deficiency in children with type 1 diabetes.
BMJ Open Diabetes Res Care
; 12(1)2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413173
5.
Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes.
Biomedicines
; 10(1)2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35052771
6.
Glucagon Levels During Short-Term SGLT2 Inhibition Are Largely Regulated by Glucose Changes in Patients With Type 2 Diabetes.
J Clin Endocrinol Metab
; 104(1): 193-201, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30137410
7.
Early Changes in Adipose Tissue Morphology, Gene Expression, and Metabolism After RYGB in Patients With Obesity and T2D.
J Clin Endocrinol Metab
; 104(7): 2601-2613, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689903
8.
FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes.
Endocrine
; 62(1): 116-128, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30032404
9.
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.
Diabetes Ther
; 9(4): 1511-1532, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29949016
10.
Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.
Adipocyte
; 7(4): 285-296, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30064293
11.
Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers.
Ups J Med Sci
; 122(4): 234-242, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29303622
Resultados
1 -
11
de 11
1
Próxima >
>>